A phase I–II study of rituximab, ifosfamide, mitoxantrone andetoposide (R-IME) for B cell non-Hodgkin’s lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT)

Robin Joyce, David Avigan, J. Ottaway et al.|Annals of Oncology|2003

Cited by 13